Blair Gage

Our job posting for 1 or more PDF positions in Vancouver Canada is now live here: tinyurl.com/4mrjw3m2

Please share/repost and apply soon!

Although it's only January, slots are filling up quickly for #GRC_Angiogenesis! If you love blood vessels and wanna dig into their interactions with their neighbors, Newport is the place to be this summer! We will soon start selecting abstracts for short talks! Don't wait, apply today. Link 👇

New year, New lab members! Welcome Hakam, Khyldoon, and Annie to the lab.

Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A | NEJM Severe hemophilia A is managed with factor VIII replacement or hemostatic products that stop or prevent bleeding. Data on gene therapy with hematopoietic stem-cell (HSC)–based expression of factor ...

www.nejm.org/doi/full/10....

Lentivirus FVIII for Hemophilia A, looks promising! Could this be a multi decade durable therapy?

Single-cell transcriptome analysis reveals CD34 as a marker of human sinoatrial node pacemaker cardiomyocytes - Nature Communications Lim et al. identify CD34 as a surface marker of the heart’s sinoatrial node pacemaker cells, enabling their isolation from stem cell differentiation cultures, advancing future disease modeling, drug d...

Congrats to the Protze lab at the McEwen Stem Cell Institute in Toronto on their first publication as a lab!
www.nature.com/articles/s41...

I'm happy to join the blusky community. We're studying hPSC derived liver endothelium to build #CellTherapy for Hemophilia and liver disease while we discovery what makes liver ECs tick. I'm actively recruiting graduate students to join us in Ottawa.

Thanks Tyler! It's so peaceful here...